Skip to content
Citation only via OpenAlex

Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation

Ragini Patel, Yogendra Sahu

Integrative Biomedical Research · 2026

Abstract

Cellular senescence(definition), an essentially irreversible growth arrest first described in cultured fibroblasts, is now recognized as a druggable driver of multiple age-related diseases, yet clinical progress has been slowed by the marked heterogeneity of senescent cells across tissues, inducing stressors, and disease states. We conducted a structured narrative synthesis of peer-reviewed literature senescence biology, single-cell senotyping, and senotherapeutic development, following informed search and appraisal strategy across PubMed/MEDLINE, Scopus, and Web of Science. Sixty-plus primary and review sources were synthesized into four evidence tables spanning first-generation agents, precision platforms, multi-tissue biomarkers, and human trials. First-generation senolytics(definition) (dasatinib plus quercetin, fisetin, navitoclax) demonstrate proof-of-concept efficacy but are constrained by dose-limiting toxicities, whereas next-generation platforms—PROTAC degraders, uPAR-directed CAR-T cells, senolytic vaccines, and galactose-caged prodrugs—achieve markedly higher predicted selectivity with lower off-target risk, operating through convergent mechanistic nodes upstream of tissue-level inflammaging(definition). Early-phase human trials corroborate target engagement but remain underpowered for definitive efficacy claims. Precision senotherapy is mechanistically justified and clinically nascent; its translational success will depend on resolving the biomarker bottleneck and matching senotype-specific vulnerabilities to intervention class.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.25163/biomedical.10110880
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Patel, R., &amp; Sahu, Y. (2026). Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. <em>Integrative Biomedical Research</em>. https://doi.org/10.25163/biomedical.10110880
Vancouver
Patel R, Sahu Y. Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. Integrative Biomedical Research. 2026. doi:10.25163/biomedical.10110880.
BibTeX
@article{ragini2026Senesc, title = {Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation}, author = {Ragini Patel and Yogendra Sahu}, journal = {Integrative Biomedical Research}, year = {2026}, doi = {10.25163/biomedical.10110880}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings